Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

167 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Active, not recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capitai Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 16 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Completed

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

NCT04604652

Conditions
Bile Duct Diseases, Bile Duct Stricture, Biliary Tract Diseases, +12 more
Locations
  • University of Miami Schiff Center for Liver Disease Miami, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Health Services Detroit, Michigan, United States
View Trial Details
Completed

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

NCT05239468

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Southern California Gastrointestinal (GI) and Liver Centers (SCLC) - Coronado Coronado, California, United States
  • Facey Medical Group Mission Hills, California, United States
  • Schiff Center for Liver Diseases / University of Miami Miami, Florida, United States
View all 26 locations
View Trial Details

Related conditions